Advertisement
Research Article| Volume 74, ISSUE 1, P61-67, January 2013

Clinical characteristics and genetic analysis in women with premature ovarian insufficiency

      Abstract

      Objective

      Premature ovarian insufficiency (POI) is defined as a primary ovarian defect characterized by absent menarche (primary amenorrhea) or premature depletion of ovarian follicles before the age of 40 (secondary amenorrhea) with hypergonadotropism and hypoestrogenism.

      Methods

      We studied the clinical, biological, and genetic data related to 50 POI patients with a mean age of menopause of 29 years (94% with secondary amenorrhea, 6% with primary amenorrhea and 15% with a family history of POI). Seventeen patients were affected by endocrine autoimmune diseases, antral follicles were observed in 31 patients by ultrasonography.

      Results

      Karyotype analysis did not show any abnormality of the X chromosome. No mutation in FSH receptor and GDF-9 genes was reported, while in one patient a variant of BMP-15 gene (A180T) was found. Four patients had fragile X mental retardation 1 gene (FMR1) premutation and one an intermediate sized CGG repeats of the same gene. Two patients with FMR1 premutation were sister and developed secondary amenorrhea at the age of 34 and 37 years. The other two patients presented with oligoamenorrhea at the age of 39 and 34 years. The patient harboured the intermediate sized CGG repeats developed secondary amenorrhea at the age of 33 years.

      Conclusions

      The genetic analysis performed on a cohort of patients with POI revealed that 8% had FMR1 premutation and only one patient a previously known variant of BMP-15 gene. No alteration of the karyotype and FSH receptor and GDF-9 genes was evidenced.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Goswami D.
        • Convay G.S.
        Premature ovarian failure.
        Hormone Research. 2007; 68: 196-202
        • Albright F.
        • Smith P.
        • Fraser R.
        A syndrome characterized by primary ovarian insufficiency and decreased stature.
        American Journal of the Medical Sciences. 1942; 204: 625-648
        • Togerson D.J.
        • Thomas R.E.
        • Reid D.M.
        Mothers and daughters menopausal ages: is there a link?.
        European Journal of Obstetrics, Gynecology, and Reproductive Biology. 1997; 74: 63-66
        • Nelson L.M.
        Primary ovarian insufficiency.
        New England Journal of Medicine. 2009; 360: 606-614
        • Welt C.K.
        Primary ovarian insufficiency: a more accurate term for premature ovarian failure.
        Clinical Endocrinology. 2008; 68: 499-509
        • De Vos M.
        • Devroey P.
        • Fauser B.C.J.M.
        Primary ovarian insufficiency.
        The Lancet. 2010; 376: 911-921
        • Vegetti W.
        • Marozzi A.
        • Manfredini E.
        • Testa G.
        • Alagna F.
        • Nicolosi A.
        • et al.
        Premature ovarian failure.
        Molecular and Cellular Endocrinology. 2000; 161: 53-57
        • Mattison D.R.
        • Evans M.I.
        • Schwimmer W.B.
        • White B.J.
        • Jensen B.
        • Schulman J.D.
        Familial premature ovarian failure.
        American Journal of Human Genetics. 1984; 36: 1341-1348
        • Vegetti W.
        • Tibiletti M.G.
        • Testa G.
        • Yankowsky de Lauretis
        • Alagna F.
        • Castaldi E.
        • et al.
        Inheritance in idiopathic premature ovarian failure: analysis of 71 cases.
        Human Reproduction. 1998; 13: 1796-1800
        • Gosden R.G.
        • Treloar S.A.
        • Martin R.G.
        • Cherkas L.F.
        • Spector T.D.
        • Fady M.J.
        • et al.
        Prevalence of premature ovarian failure in monozygotic and dizygotic twins.
        Human Reproduction. 2007; 22: 610-615
        • Shimasaki S.
        • Moore R.K.
        • Otsuka F.
        • Eirickson G.F.
        The bone morphogenetic protein system in mammalian reproduction.
        Endocrine Reviews. 2004; 25: 72-101
        • Persani L.
        • Rossetti R.
        • Cacciatore C.
        • Bonomi M.
        Primary ovarian insufficiency: X chromosome defects and autoimmunity.
        Journal of Autoimmunity. 2009; 33: 35-41
        • Aittomaki K.
        • Lucena J.L.
        • Pakarinen P.
        • Sistonen P.
        • Tapanainen J.
        • Gromol J.
        • et al.
        Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure.
        Cell. 1995; 82: 959-968
        • Touraine P.
        • Beau I.
        • Gougeon A.
        • Meduri G.
        • Desroches A.
        • Pichard C.
        • et al.
        New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype.
        Molecular Endocrinology. 1999; 13: 1844-1854
        • Doherty E.
        • Pakarinen P.
        • Tiitinen A.
        • Kiilavuori A.
        • Huhtaniemi I.
        • Forrest S.
        • et al.
        A Novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure.
        Journal of Clinical Endocrinology and Metabolism. 2002; 87: 1151-1155
        • Di Pasquale E.
        • Beck-Peccoz P.
        • Persani L.
        Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene.
        American Journal of Human Genetics. 2004; 75: 106-111
        • Laissue P.
        • Christin-Maitre S.
        • Touraine P.
        • Kuttenn F.
        • Ritvos O.
        • Aittomaki K.
        • et al.
        Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure.
        European Journal of Endocrinology/European Federation of Endocrine Societies. 2006; 154: 739-744
        • Dixit H.
        • Rao L.K.
        • Padmalatha V.V.
        • Kanakavalli M.
        • Deenadayal M.
        • Gupta N.
        • et al.
        Missense mutations in the BMP15 gene are associated with ovarian failure.
        Human Genetics. 2006; 119: 408-415
        • Ledig S.
        • Ropke A.
        • Haeusler G.
        • Hinney B.
        • Wieacker P.
        BMP15 mutations in XX gonadal dysgenesis and premature ovarian failure.
        American Journal of Obstetrics and Gynecology. 2008; 198: 841-845
        • Di Pasquale E.
        • Rossetti R.
        • Marozzi A.
        • Bodega B.
        • Borgato S.
        • Cavallo L.
        Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure.
        Journal of Clinical Endocrinology and Metabolism. 2006; 91: 1976-1979
        • Rossetti R.
        • Di Pasquale E.
        • Marozzi A.
        • Bione S.
        • Toniolo D.
        • Grammatico P.
        • et al.
        BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein.
        Human Mutation. 2009; 30: 804-810
        • Tiotiu D.
        • Alvaro Mercadal B.
        • Imbert R.
        • Verbist J.
        • Demeestere I.
        • De Leener A.
        • et al.
        Variants of the BMP-15 gene in a cohort of patients with premature ovarian failure.
        Human Reproduction. 2010; 25: 1581-1587
        • Zhao X.X.
        • Suzumori N.
        • Yamaguchi M.
        • Suzumori K.
        Mutational analysis of the homeobox region of the human NOBOX gene in Japanese women who exhibit premature ovarian failure.
        Fertility and Sterility. 2005; 83: 1843-1844
        • Mansouri M.R.
        • Schuster J.
        • Badhai J.
        • Stattin E.L.
        • Lösel R.
        • Wehling M.
        • et al.
        Alterations in the expression, structure and function of progestron receptor membrane component – I (PGRMCI) in premature ovarian failure.
        Human Molecular Genetics. 2008; 17: 3776-3783
        • Zhao H.
        • Chen Z.J.
        • Quin Y.
        • Shi Y.
        • Wang S.
        • Choi Y.
        • et al.
        Transcription factor FIGLA is mutated in patients with premature ovarian failure.
        American Journal of Human Genetics. 2008; 82: 1342-1348
        • Laurenco D.
        • Brauner R.
        • Lin L.
        • De Perdigo A.
        • Weryha G.
        • Muresam M.
        • et al.
        Mutations in NR5A1 associated with ovarian insufficiency.
        New England Journal of Medicine. 2009; 360: 1200-1210
        • Dixit H.
        • Rao L.K.
        • Padmalatha V.
        • Kanakavalli M.
        • Deenadayal M.
        • Gupta N.
        • et al.
        Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure.
        Menopause. 2005; 12: 749-754
        • Bodega B.
        • Bione S.
        • Dalpra L.
        • Toniolo D.
        • Ornaghi F.
        • Vegetti W.
        • et al.
        Influence of intermediate and uninterrupted FMRI CGG expansions in premature ovarian manifestation.
        Human Reproduction. 2006; 21: 952-957
        • Bennett C.E.
        • Conway G.S.
        • Macpherson J.N.
        • Jacobs P.A.
        • Murray A.
        Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failure.
        Hum Reprod. 2010; 25: 1335-1338
        • Bachelot A.
        • Rouxel A.
        • Massin N.
        • Dulon J.
        Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure.
        European Journal of Endocrinology/European Federation of Endocrine Societies. 2009; 161: 179-187
        • Snieder H.
        • MacGregor A.J.
        • Spector T.D.
        Genes control the cessation of woman's reproductive life: a twin study of hysterectomy and age at menopause.
        Journal of Clinical Endocrinology and Metabolism. 1998; 83: 1875-1880
        • Husebye E.S.
        • Løvås K.
        Immunology of Addison's disease and premature ovarian failure.
        Endocrinology and Metabolism Clinics of North America. 2009; 38: 389-395
        • Betterle C.
        • Rossi A.
        • Dalla Pria S.
        • Artifoni A.
        • Pedini B.
        • Gavasso S.
        • et al.
        Premature ovarian failure: autoimmunity and natural history.
        Clinical Endocrinology (Oxford). 1993; 39: 35-43
        • Sotsiou F.
        • Bottazzo G.F.
        • Doniach D.
        Immunofluorescence studies on autoantibodies to steroid-producing cells and germline cells in endocrine diseases and infertilità.
        Clinical and Experimental Immunology. 1980; 39: 97-111
        • La Marca A.
        • Marzotti S.
        • Brozzetti A.
        • Stabile G.
        • Artenisio A.C.
        • Bini V.
        • et al.
        Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with preserved pool of functioning follicles.
        Journal of Clinical Endocrinology and Metabolism. 2009; 94: 3816-3823
        • Tonacchera M.
        • Ferrarini E.
        • Dimida A.
        • Agretti P.
        • De Marco G.
        • De Servi M.
        • et al.
        Gonadotropin receptor blocking antibodies measured by the use of cell lines stably expressing human gonadotropin receptors are not detectable in women with 46,XX premature ovarian failure.
        Clinical Endocrinology. 2004; 61: 376-381
        • Gleicher N.
        • Barad D.H.
        The FMR1 gene as regulator of ovarian recruitment and ovarian reserve.
        Obstetrical and Gynecological Survey. 2010; 65: 523-530
        • Moron F.J.
        • Mendoza N.
        • Quereda F.
        • Vazquez F.
        • Ramirez-Lorca R.
        • Velasco J.
        • et al.
        Pyrosequencing technology for automated detection of the BMP15 A180T variant in Spanish post menopausal women.
        Clinical Endocrinology. 2007; 53: 1162-1164
        • Zhao Z.Z.
        • Painte J.M.
        • Palmer J.S.
        • Webb P.M.
        • Hayward N.K.
        • Whiteman D.C.
        • et al.
        Variation in bone morphogenetic protein 15 is not associated with spontaneous human dizygotic twinning.
        Human Reproduction. 2008; 23: 2372-2379